Atlas Trials

N-Acetyl Cysteine and Aspirin as an Adjunctive Treatment for Bipolar Disorder

Clinical trial NCT01797575 · COMPLETED

Trial details

NCT number
NCT01797575
Sponsor
The University of Texas Health Science Center, Houston
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Bipolar Disorder
Start date
2013-01-01
Primary completion
2017-02-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.